bioMerieux CE Mark of VIDAS Serology test for SARS-COV-2

26 May, 2020

bioMérieux announces the CE marking of VIDAS^® anti-SARS-CoV-2 serology tests to detect antibodies in people who have been exposed to SARS-CoV-2 which causes the COVID-19 disease.